Intelligent Approach for Clustering Mutations’ Nature of COVID-19 Genome
Source abstract
Abstract
In December 2019, a group of people in Wuhan city of Hubei province of China were found to be affected by an infection called dark etiology pneumonia. The outbreak of this pneumonia infection was declared a deadly disease by the China Center for Disease Control and Prevention on January 9, 2020, named Novel Coronavirus 2019 (nCoV-2019). This nCoV-2019 is now known as COVID-19. There is a big list of infections of this coronavirus which is present in the form of a big family. This virus can cause several diseases that usually develop with a serious problem. According to the World Health Organization (WHO), 2019-nCoV has been placed as the modern generation of Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS) coronaviruses, so COVID-19 can repeatedly change its internal genome structure to extend its existence. Understanding and accurately predicting the mutational properties of the genome structure of COVID-19 can form a good leadership role in preventing and fighting against coronavirus. In this research paper, an analytical approach has been presented which is based on the k-means cluster technique of machine learning to find the clusters over the mutational properties of the COVID-19 viruses’ complete genome. This method would be able to act as a promising tool to monitor and track pathogenic infections in their stable and local genetics/hereditary varieties. This paper identifies five main clusters of mutations with as best in most cases in the coronavirus that could help scientists and researchers develop disease control vaccines for the transformation of coronaviruses.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: SARS-CoV-2 and COVID-19 Research · vaccines and immunoinformatics approaches · Computational Drug Discovery Methods
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (27)
Show source-provided references
1. World Health Organization. (2020). Coronavirus disease 2019 (COVID-19): Situation report, 72. World Health Organization. https://apps.who.int/iris/handle/10665/331685.
2. A novel coronavirus from patients with pneumonia in China, 201910.1056/NEJMoa2001017 ↗
3. Middle East respiratory syndrome: Emergence of a pathogenic human coronavirus10.1146/annurev-med-051215-031152 ↗
4. Middle East respiratory syndrome coronavirus (MERS-CoV) origin and animal reservoir10.1186/s12985-016-0544-0 ↗
5. A pneumonia outbreak associated with a new coronavirus of probable bat origin10.1038/s41586-020-2012-7 ↗
6. On the origin and continuing evolution of SARS-CoV-210.1093/nsr/nwaa036 ↗
7. Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans10.1128/mBio.00473-12 ↗
8. Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: Implications for pathogenesis and virus transmission pathways10.1002/path.1560 ↗
9. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR10.2807/1560-7917.ES.2020.25.3.2000045 ↗
10. Emerging coronaviruses: Genome structure, replication, and pathogenesis10.1002/jmv.25681 ↗
11. SARS—beginning to understand a new virus10.1038/nrmicro775 ↗
12. siRNA targeting the leader sequence of SARS-CoV inhibits virus replication10.1038/sj.gt.3302479 ↗
13. Nsp3 of coronaviruses: Structures and functions of a large multi-domain protein10.1016/j.antiviral.2017.11.001 ↗
14. Pathogenicity and transmissibility of 2019-nCoV—a quick overview and comparison with other emerging viruses10.1016/j.micinf.2020.01.004 ↗
15. Nuclear magnetic resonance structure of the nucleic acid-binding domain of severe acute respiratory syndrome coronavirus nonstructural protein 310.1128/JVI.01253-09 ↗
16. Coronavirus main proteinase (3CLpro) structure: Basis for design of anti-SARS drugs10.1126/science.1085658 ↗
17. Severe acute respiratory syndrome coronavirus nonstructural proteins 3, 4, and 6 induce double-membrane vesicles10.1128/mBio.00524-13 ↗
18. Identification of severe acute respiratory syndrome coronavirus replicase products and characterization of papain-like protease activity10.1128/JVI.78.24.13600-13612.2004 ↗
19. The nsp9 replicase protein of SARS-coronavirus, structure and functional insights10.1016/j.str.2004.01.016 ↗
20. A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 210.1074/jbc.C300520200 ↗
21. The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade10.1016/j.antiviral.2020.104742 ↗
22. Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response10.1128/JVI.02232-10 ↗
23. Characterization of protein–protein interactions between the nucleocapsid protein and membrane protein of the SARS coronavirus10.1016/j.virusres.2004.05.002 ↗
24. Clinical characteristics of coronavirus disease 2019 in China10.1056/NEJMoa2002032 ↗
25. An improved K-means clustering algorithm
26. Performances of K-means clustering algorithm with different distance metrics10.32604/iasc.2021.019067 ↗
27. GBK-Means clustering algorithm: An improvement to the K-means algorithm based on the bargaining game10.1016/j.knosys.2020.106672 ↗